企业新闻｜粒曼公司战略及细胞编辑产品线发布！
2025-12-29
开启工业化细胞编辑新时代
粒曼生物：以工业化高通量平台，重新定义基因功能发现
在粒曼生物（ELEM Biotech），我们正在消除基因编辑中的技术瓶颈，将复杂的生物学实验转化为标准化、规模化的工业生产。我们致力于建立细胞体外编辑行业的黄金准则：【杞梓标准】，通过自主研发的智能化高通量体外细胞编辑平台，为全球新药研发和基础科研提供确定性。
【工业级交付周期：让研发重回快车道】
在时间就是生命的生物制药领域，我们深知速度的意义。
- 规模化产能：凭借每月1,000+ KO细胞池的强悍生产能力，我们已完成人全基因组19,883个基因的敲除验证。
- 极速交付：依靠标准化及自动化流水线，我们将原本数月的编辑周期缩短至周级别，确保您的候选药物筛选和基础研究始终领先一步。
【全方位技术矩阵：一站式细胞编辑解决方案】
我们提供覆盖基因功能研究全生命周期的定制化服务，满足多样化的实验需求：
- 核心服务： 涵盖基因敲除（KO）、敲低（KD）、过表达（OE）、精准点突变（Point Mutation）及基因敲入（KI）等全类型编辑方案（产品及服务）。
- 灵活定制：无论是阵列文库还是单克隆构建，我们均能提供高成功率的专业支持。
【“杞梓标准”：定义行业质量天花板】
速度不以牺牲质量为代价。粒曼生物建立并践行严苛的“杞梓标准”：
- 双重验证： 不同于行业通用的单一维度检测，我们对每一株细胞进行“基因水平（DNA）与蛋白水平（Protein）”的全面严格质控，确保“所编即所得”。
- 极致纯净：在1,000平方的专业 BSL-2 实验室中，实行“零容忍”的支原体污染控制与环境检测，保障实验数据的纯净与可复现。
- 全球合规：完善的质量管理体系与进出口资质（基因编辑细胞特殊物品），让我们成为数百家国内外顶尖药企、CRO及科研机构的长期信赖伙伴。
粒曼生物：用工业的力量加速创新，让高质量基因编辑触手可及。
Ushering in the Era of Industrial-Scale Cell Engineering
ELEM: Redefining Functional Genomics with an Automated, High-Throughput Platform
At ELEM Biotech, we are transforming gene editing from a specialized laboratory craft into a powerful, industrial-scale discovery engine. By merging cutting-edge automation with the uncompromising "Qizi Standard," we provide the biological foundation that accelerates the journey from benchtop to bedside.
【Industrial-Scale Delivery: Accelerating Your Timeline】
In the race to develop life-saving therapies, speed is the ultimate competitive advantage.
- Massive Capacity: With an output of 1,000+ customized KO cell pools per month, we have already validated 19,883 human genes at the genome-wide level.
- Rapid Turnaround: Our intelligent automation platform slashes lead times from months to weeks, ensuring your R&D pipeline remains agile and ahead of schedule.
【Comprehensive Service Suite: Your One-Stop Engineering Partner】
We offer a full spectrum of cell editing solutions designed to meet the diverse needs of modern drug discovery:
- End-to-End Solutions: Our expertise spans Knockout (KO), Knockdown (KD), Overexpression (OE), Point Mutation, and Knock-in (KI) services.
- Tailored Precision: From high-throughput arrayed libraries to complex single-clone engineering, we deliver consistent results across all editing modalities.
【The Qizi Standard: Uncompromising Quality Control】
Speed is nothing without accuracy. Liman Bio’s proprietary "Qizi Standard" ensures that every cell line meets the highest scientific rigors:
- Dual-Level Validation: We confirm every edit at both the Genomic (DNA) and Proteomic (Protein) levels. We don't just report a knockout; we prove functional loss.
- Zero-Contamination Protocols: Operating in a 1,000㎡ state-of-the-art BSL-2 facility, we implement the industry’s strictest mycoplasma screening and environmental controls.
- Global Trust & Compliance: With full import/export certifications and a robust Quality Management System, we are the partner of choice for hundreds of pharmaceutical giants, CROs, and elite research institutes worldwide.
ELEM Biotech: Empowering Discovery through Industrial Precision. Reliable Cells. Rapid Results. Real Breakthroughs.
上一页：
2025 /
12-29
所属分类：
行业新闻
相关资讯—
2025-12-29
2025-12-29
2025-12-29